Modern Approaches to the Treatment of Acute Facial Pain.

Publisher: Current Science Inc Country of Publication: United States NLM ID: 100970666 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-3081 (Electronic) Linking ISSN: 15343081 NLM ISO Abbreviation: Curr Pain Headache Rep Subsets: MEDLINE

Original Publication: Philadelphia, PA : Current Science Inc., c2001-

Facial Pain*/therapy ; Acute Pain*/therapy; Humans ; Pain Management/methods

Purpose of Review: Acute facial pain presents a complex challenge in medical practice, requiring a comprehensive and interdisciplinary approach to its management. This narrative review explores the contemporary landscape of treating acute facial pain, delving into pharmacological, non-pharmacological, and advanced interventions. The significance of tailored treatment strategies, rooted in the diverse etiologies of facial pain, such as dental infections, trigeminal neuralgia, temporomandibular joint disorders, sinusitis, or neurological conditions like migraines or cluster headaches, is underscored. We particularly emphasize recent advances in treating trigeminal neuralgia, elucidating current treatment concepts in managing this particular acute facial pain.
Recent Findings: Recent research sheds light on various treatment modalities for acute facial pain. Pharmacotherapy ranges from traditional NSAIDs and analgesics to anticonvulsants and antidepressants. Non-pharmacological interventions, including physical therapy and psychological approaches, play pivotal roles. Advanced interventions, such as nerve blocks and surgical procedures, are considered in cases of treatment resistance. Moreover, we explore innovative technologies like neuromodulation techniques and personalized medicine, offering promising avenues for optimizing treatment outcomes in acute facial pain management. Modern management of acute facial pain requires a nuanced and patient-centric approach. Tailoring treatment strategies to the individual's underlying condition is paramount. While pharmacotherapy remains a cornerstone, the integration of non-pharmacological interventions is essential for comprehensive care. Advanced interventions should be reserved for cases where conservative measures prove inadequate. Furthermore, leveraging innovative technologies and personalized medicine holds promise for enhancing treatment efficacy. Ultimately, a holistic approach that considers the diverse needs of patients is crucial for effectively addressing acute facial pain.
(© 2024. The Author(s).)

Dent Update. 2011 Jul-Aug;38(6):396-400, 402-3, 405-6 passim. (PMID: 21905353)
Cureus. 2022 Jul 14;14(7):e26856. (PMID: 35974855)
World Neurosurg. 2019 Aug;128:e74-e80. (PMID: 30954750)
World Neurosurg. 2022 Feb;158:226-233. (PMID: 34875391)
BMC Oral Health. 2024 Jan 13;24(1):78. (PMID: 38218874)
Pain Physician. 2017 Sep;20(6):E873-E881. (PMID: 28934792)
J Pain Res. 2019 Sep 09;12:2709-2722. (PMID: 31564962)
Pain Pract. 2010 Jul-Aug;10(4):370-4. (PMID: 20492576)
F1000Res. 2019 Apr 17;8:. (PMID: 31069052)
BJA Educ. 2020 Apr;20(4):120-125. (PMID: 33456940)
Curr Pain Headache Rep. 2016 Apr;20(4):24. (PMID: 26896948)
J Neurosurg. 2024 Feb 16;:1-13. (PMID: 38364220)
J Pain Res. 2021 Nov 03;14:3437-3463. (PMID: 34764686)
Front Neurol. 2022 Nov 09;13:1018268. (PMID: 36438943)
Curr Pain Headache Rep. 2023 Sep;27(9):437-444. (PMID: 37392334)
J Korean Neurosurg Soc. 2022 Sep;65(5):615-621. (PMID: 35430788)
J Pain Res. 2014 Feb 21;7:99-115. (PMID: 24591846)
J Pain Res. 2022 Sep 29;15:3059-3068. (PMID: 36199499)
J Neurosurg. 2018 Dec 7;131(5):1532-1540. (PMID: 30544341)
Acta Neurochir (Wien). 2023 Dec;165(12):3877-3885. (PMID: 37955684)
Cureus. 2023 Mar 15;15(3):e36193. (PMID: 37065382)
Math Biosci Eng. 2024 Mar 7;21(4):5335-5359. (PMID: 38872538)
Neuroreport. 2014 Jun 18;25(9):715-7. (PMID: 24780896)
Saudi Dent J. 2023 Jul;35(5):395-402. (PMID: 37520608)
Drugs. 2018 Sep;78(14):1433-1442. (PMID: 30178160)
Brain Sci. 2023 Mar 14;13(3):. (PMID: 36979302)
Curr Pain Headache Rep. 2019 Aug 6;23(10):74. (PMID: 31388843)
Front Neurol. 2022 Jul 06;13:923225. (PMID: 35873781)
Neurosurgery. 2020 Feb 1;86(2):182-190. (PMID: 30892607)
Otolaryngol Clin North Am. 2013 Jun;46(3):367-82. (PMID: 23764815)
J Craniofac Surg. 2020 Oct;31(7):e685-e688. (PMID: 32472880)
Neurosurgery. 2021 Sep 15;89(4):557-564. (PMID: 34325470)
Eur J Neurol. 2019 Jun;26(6):831-849. (PMID: 30860637)
Cureus. 2023 Aug 17;15(8):e43645. (PMID: 37719619)
Surg Neurol Int. 2014 Jul 30;5:118. (PMID: 25101213)
Neurol India. 2018 May-Jun;66(3):688-694. (PMID: 29766927)
Acta Neurol Belg. 2023 Dec;123(6):2295-2302. (PMID: 37353706)
Curr Neuropharmacol. 2020;18(2):109-119. (PMID: 31608834)
Ann Palliat Med. 2022 Apr;11(4):1391-1400. (PMID: 35523747)
J Neurosurg. 2018 Apr 27;130(3):733-757. (PMID: 29701555)
Pract Neurol. 2021 Oct;21(5):392-402. (PMID: 34108244)
BMJ. 2014 Feb 17;348:g474. (PMID: 24534115)
Neurosciences (Riyadh). 2015 Apr;20(2):107-14. (PMID: 25864062)
BMC Surg. 2023 Oct 27;23(1):331. (PMID: 37891595)
Neurosurg Clin N Am. 2014 Oct;25(4):743-9. (PMID: 25240661)
Exp Ther Med. 2022 Jan;23(1):17. (PMID: 34815769)
SAGE Open Med. 2021 Jun 3;9:20503121211022197. (PMID: 34158937)
Acta Neurol Belg. 2022 Aug;122(4):1019-1030. (PMID: 33988820)
Curr Pain Headache Rep. 2023 Aug;27(8):209-216. (PMID: 37285010)
Toxins (Basel). 2023 Sep 01;15(9):. (PMID: 37755967)
Stereotact Funct Neurosurg. 2016;94(2):75-85. (PMID: 27071078)
Neurologia (Engl Ed). 2023 Nov-Dec;38(9):625-634. (PMID: 37996213)
J Oral Maxillofac Res. 2020 Jun 30;11(2):e2. (PMID: 32760475)
Br J Anaesth. 2019 Aug;123(2):e385-e396. (PMID: 31208761)
Biomedicines. 2023 Sep 22;11(10):. (PMID: 37892981)
Br J Anaesth. 2013 Jul;111(1):95-104. (PMID: 23794651)
Biomedicines. 2023 Aug 21;11(8):. (PMID: 37626811)
J Korean Neurosurg Soc. 2022 Sep;65(5):622-632. (PMID: 35678088)
Pain Res Manag. 2017;2017:7438326. (PMID: 28827979)
N Engl J Med. 2020 Aug 20;383(8):754-762. (PMID: 32813951)
Lancet Neurol. 2020 Sep;19(9):784-796. (PMID: 32822636)
Pain Physician. 2019 Sep;22(5):447-477. (PMID: 31561646)
Acta Neurochir (Wien). 2021 Jun;163(6):1623-1634. (PMID: 33751217)
J Neurosurg. 2019 Feb 1;132(2):639-646. (PMID: 30717044)
Cephalalgia. 2023 Aug;43(8):3331024231187160. (PMID: 37548299)
Acta Neurochir (Wien). 2017 Nov;159(11):2127-2135. (PMID: 28905114)
Continuum (Minneap Minn). 2017 Apr;23(2, Selected Topics in Outpatient Neurology):396-420. (PMID: 28375911)
Curr Pain Headache Rep. 2022 May;26(5):357-364. (PMID: 35230591)
Br Dent J. 2017 Dec;223(9):639-647. (PMID: 29074941)
J Pain Res. 2019 Jan 18;12:423-441. (PMID: 30697063)
Neuropsychiatr Dis Treat. 2023 Sep 19;19:2007-2012. (PMID: 37745191)
Toxins (Basel). 2020 Feb 11;12(2):. (PMID: 32053883)
Brain Sci. 2022 Sep 09;12(9):. (PMID: 36138952)
J Dent Anesth Pain Med. 2021 Oct;21(5):379-396. (PMID: 34703889)
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):225-31. (PMID: 21236592)
Lancet Neurol. 2006 Mar;5(3):257-67. (PMID: 16488381)
J Neurosurg. 2024 Jan 26;140(6):1777-1784. (PMID: 38277665)
J Clin Neurosci. 2008 May;15(5):516-9. (PMID: 18378142)

Keywords: Acute pain; facial; Intervention; Medical treatment; Surgery

Date Created: 20240507 Date Completed: 20240725 Latest Revision: 20240728

20240728

PMC11272677

10.1007/s11916-024-01260-4

38713367